


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.24%
+1.33%
+105.64%
+1.08%
BSX
Boston Scientific
$103.90
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Investors losing their confidence
Technical Indicators

5+ Days Up
Chart
$99.24 (+4.70%)
$105.21 (-1.25%)
$104.29 (-0.37%)
$90.75 (+14.49%)
BSX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

BSX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
BSX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BSX Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displaySYK
366.52
-1.85%
BDX
193.17
+0.07%
TFX
107.20
-2.05%
RMD
246.59
-2.27%
PROF
6.70
+5.26%
What is BSX current stock price?
What are BSX stock strengths?
What risks are associated with BSX stock?
When is BSX next earnings report?
What is BSX market cap and volume?
What is BSX's current Stock IQ?
Should I buy BSX stock right now?
Is BSX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BSX?
What does a 'Strong Sell' rating mean for BSX?
What factors influence BSX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.24%
+1.33%
+105.64%
+1.08%
BSX
Boston Scientific
Current Price
$103.90
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Investors losing their confidence
Technical Indicators

5+ Days Up
Linked to BSX
SYK
366.52
-1.85%
BDX
193.17
+0.07%
TFX
107.20
-2.05%
RMD
246.59
-2.27%
PROF
6.70
+5.26%

Chart
$99.24 (+4.70%)
$105.21 (-1.25%)
$104.29 (-0.37%)
$90.75 (+14.49%)
BSX Analysts Opinion
BSX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
BSX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BSX Street Sentiment is bullish and have positive views on the near-term outlook
BSX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
BSX Latest Analysis
Boston Scientific Up 7% in a Month: How Should You Play the Stock?. BSXs month-long rally strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.
Today
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings. Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23 UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) shares and increased its price target to $140 from $135. The price target raise comes after Boston Scientifics quarterly results which showed organic sales and [….]
Today
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors. Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
Wed Nov 12, 2025
BSX Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Wed Nov 12, 2025
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet. Based on the average brokerage recommendation (ABR) Boston Scientific (BSX) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So is the stock worth buying?
Tue Nov 11, 2025
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think &.Yes&.. Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.
Mon Nov 10, 2025
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Mon Nov 10, 2025
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Fri Nov 7, 2025
BSX Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Wed Nov 5, 2025
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?. BSXs Q3 EP sales soar 63% on FARAPULSE momentum FDA label expansion and rising global adoption.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.